Independent Advisor Alliance Pmv Pharmaceuticals, Inc. Transaction History
Independent Advisor Alliance
- $2.95 Billion
- Q1 2025
A detailed history of Independent Advisor Alliance transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Independent Advisor Alliance holds 12,500 shares of PMVP stock, worth $18,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,500
Previous 12,514
0.11%
Holding current value
$18,000
Previous $18,000
27.78%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PMVP
# of Institutions
62Shares Held
40.4MCall Options Held
1.8KPut Options Held
100-
Orbimed Advisors LLC San Diego, CA6.48MShares$9.32 Million0.22% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.75MShares$5.4 Million3.31% of portfolio
-
Sio Capital Management, LLC New York, NY3.74MShares$5.38 Million1.53% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.31MShares$4.76 Million0.07% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA3.3MShares$4.75 Million0.29% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $65.7M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...